Autophagy in brain tumors: A new target for therapeutic intervention

Brain Pathology

Volumn 22, Issue 1, 2012, Pages 89-98

  Kaza, Niroop ^a   Kohli, Latika ^a,b   Roth, Kevin A ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

BCL 2; BECLIN1; Combinatorial therapy; Glioblastoma; LC3

Indexed keywords

1 (1 CYANO 1 METHYLETHYL) 3 METHYL 8 (3 QUINOLINYL)IMIDAZO[4,5 C]QUINOLIN 2(1H,3H) ONE; 2 (4 HYDROXYPHENYL) 4 MORPHOLINOPYRIDO[3',2':4,5]FURO[3,2 D]PYRIMIDINE; 3 METHYLADENINE; ANTINEOPLASTIC AGENT; ARSENIC TRIOXIDE; BAFILOMYCIN A1; BECLIN 1; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; CANNABINOID; CETUXIMAB; CHLOROQUINE; DACTINOMYCIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; GAMMA INTERFERON; GEFITINIB; IMATINIB; KU 0063794; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MONENSIN; NEUROFIBROMIN; PANITUMUMAB; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P53; RESVERATROL; TAMOXIFEN; TEMOZOLOMIDE; TEMSIROLIMUS; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; AUTOPHAGY; BRAIN TUMOR; CANCER THERAPY; CARCINOGENESIS; CELL DEATH; CELL ELONGATION; CELL STRESS; CELL VACUOLE; CONFERENCE PAPER; GENE MUTATION; GENETIC SCREENING; GENOMIC INSTABILITY; GLIOBLASTOMA; GLYCOLYSIS; HUMAN; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; AUTOPHAGY; BRAIN NEOPLASMS; CELL TRANSFORMATION, NEOPLASTIC; DRUG DESIGN; GLIOMA; HUMANS; MUTATION;

EID: 83455197015     PISSN: 10156305     EISSN: 17503639     Source Type: Journal    
DOI: 10.1111/j.1750-3639.2011.00544.x     Document Type: Conference Paper

References (100)

1. Alonso MM, Jiang H, Yokoyama T, Xu J, Bekele NB, Lang FF, et al, (2008) Delta-24-RGD in combination with RAD001 induces enhanced anti-glioma effect via autophagic cell death. Mol Ther 16: 487-493. (Pubitemid 351314987)
2. Aoki H, Kondo Y, Aldape K, Yamamoto A, Iwado E, Yokoyama T, et al, (2008) Monitoring autophagy in glioblastoma with antibody against isoform B of human microtubule-associated protein 1 light chain 3. Autophagy 4: 467-475. (Pubitemid 351705143)
3. Arico S, Petiot A, Bauvy C, Dubbelhuis PF, Meijer AJ, Codogno P, Ogier-Denis E, (2001) The tumor suppressor PTEN positively regulates macroautophagy by inhibiting the phosphatidylinositol 3-kinase/protein kinase B pathway. J Biol Chem 276: 35243-35246.
4. Bellot G, Garcia-Medina R, Gounon P, Chiche J, Roux D, Pouyssegur J, Mazure NM, (2009) Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains. Mol Cell Biol 29: 2570-2581.
5. Carrasco-Garcia E, Saceda M, Grasso S, Rocamora-Reverte L, Conde M, Gomez-Martinez A, et al, (2011) Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines. Exp Cell Res 317: 1476-1489.
6. CBTRUS (2011) CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2004-2007. Hinsdale, IL.
7. Chang SM, Wen P, Cloughesy T, Greenberg H, Schiff D, Conrad C, et al, (2005) Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 23: 357-361. (Pubitemid 40980358)
8. Chen N, Karantza V, (2011) Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157-168.
9. Cheng CK, Fan QW, Weiss WA, (2009) PI3K signaling in glioma-animal models and therapeutic challenges. Brain Pathol 19: 112-120.
10. Chiu HW, Ho SY, Guo HR, Wang YJ, (2009) Combination treatment with arsenic trioxide and irradiation enhances autophagic effects in U118-MG cells through increased mitotic arrest and regulation of PI3K/Akt and ERK1/2 signaling pathways. Autophagy 5: 472-483.
11. Crighton D, Wilkinson S, O'Prey J, Syed N, Smith P, Harrison PR, et al, (2006) DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126: 121-134. (Pubitemid 44040988)
12. Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S, (2004) Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 64: 4286-4293. (Pubitemid 38802435)
13. Daido S, Yamamoto A, Fujiwara K, Sawaya R, Kondo S, Kondo Y, (2005) Inhibition of the DNA-dependent protein kinase catalytic subunit radiosensitizes malignant glioma cells by inducing autophagy. Cancer Res 65: 4368-4375. (Pubitemid 40775676)
14. De Duve C, Wattiaux R, (1966) Functions of lysosomes. Annu Rev Physiol 28: 435-492.
15. Degenhardt K, Mathew R, Beaudoin B, Bray K, Anderson D, Chen G, et al, (2006) Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10: 51-64.
16. Degtyarev M, De Maziere A, Orr C, Lin J, Lee BB, Tien JY, et al, (2008) Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. J Cell Biol 183: 101-116.
17. Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, Laharanne E, Veron N, et al, (2011) Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death. Cancer Biol Ther 11: 1017-1027.
18. Fan QW, Knight ZA, Goldenberg DD, Yu W, Mostov KE, Stokoe D, et al, (2006) A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 9: 341-349. (Pubitemid 43668732)
19. Fan QW, Cheng CK, Nicolaides TP, Hackett CS, Knight ZA, Shokat KM, Weiss WA, (2007) A dual phosphoinositide-3-kinase alpha/mTOR inhibitor cooperates with blockade of epidermal growth factor receptor in PTEN-mutant glioma. Cancer Res 67: 7960-7965. (Pubitemid 47395125)
20. Fan QW, Cheng C, Hackett C, Feldman M, Houseman BT, Nicolaides T, et al, (2010) Akt and autophagy cooperate to promote survival of drug-resistant glioma. Sci Signal 3: ra81.
21. Feng Z, Zhang H, Levine AJ, Jin S, (2005) The coordinate regulation of the p53 and mTOR pathways in cells. Proc Natl Acad Sci USA 102: 8204-8209. (Pubitemid 40800067)
22. Feng Z, Hu W, de Stanchina E, Teresky AK, Jin S, Lowe S, Levine AJ, (2007) The regulation of AMPK beta1, TSC2, and PTEN expression by p53: stress, cell and tissue specificity, and the role of these gene products in modulating the IGF-1-AKT-mTOR pathways. Cancer Res 67: 3043-3053. (Pubitemid 46724841)
23. Fimia GM, Stoykova A, Romagnoli A, Giunta L, Di Bartolomeo S, Nardacci R, et al, (2007) Ambra1 regulates autophagy and development of the nervous system. Nature 447: 1121-1125. (Pubitemid 47014434)
24. Franceschi E, Cavallo G, Lonardi S, Magrini E, Tosoni A, Grosso D, et al, (2007) Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Br J Cancer 96: 1047-1051. (Pubitemid 46608313)
25. Fujita N, Itoh T, Omori H, Fukuda M, Noda T, Yoshimori T, (2008) The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol Biol Cell 19: 2092-2100.
26. Fung C, Lock R, Gao S, Salas E, Debnath J, (2008) Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell 19: 797-806. (Pubitemid 351481798)
27. Galanis E, Buckner JC, Maurer MJ, Kreisberg JI, Ballman K, Boni J, et al, (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23: 5294-5304. (Pubitemid 46206983)
28. Ge PF, Zhang JZ, Wang XF, Meng FK, Li WC, Luan YX, et al, (2009) Inhibition of autophagy induced by proteasome inhibition increases cell death in human SHG-44 glioma cells. Acta Pharmacol Sin 30: 1046-1052.
29. Geng Y, Kohli L, Klocke BJ, Roth KA, (2010) Chloroquine-induced autophagic vacuole accumulation and cell death in glioma cells is p53 independent. Neuro-oncol 12: 473-481.
30. Guo JY, Chen HY, Mathew R, Fan J, Strohecker AM, Karsli-Uzunbas G, et al, (2011) Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25: 460-470.
31. Hanada T, Noda NN, Satomi Y, Ichimura Y, Fujioka Y, Takao T, et al, (2007) The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem 282: 37298-37302.
32. Hanahan D, Weinberg RA, (2000) The hallmarks of cancer. Cell 100: 57-70. (Pubitemid 30046295)
33. He C, Klionsky DJ, (2009) Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 43: 67-93.
34. Herrera VA, Zeindl-Eberhart E, Jung A, Huber RM, Bergner A, (2011) The dual PI3K/mTOR inhibitor BEZ235 is effective in lung cancer cell lines. Anticancer Res 31: 849-854.
35. Hetschko H, Voss V, Senft C, Seifert V, Prehn JH, Kogel D, (2008) BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells. Neoplasia 10: 873-885.
36. Huang X, Bai HM, Chen L, Li B, Lu YC, (2010) Reduced expression of LC3B-II and Beclin 1 in glioblastoma multiforme indicates a down-regulated autophagic capacity that relates to the progression of astrocytic tumors. J Clin Neurosci 17: 1515-1519.
37. Itakura E, Kishi C, Inoue K, Mizushima N, (2008) Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 19: 5360-5372.
38. Ito H, Daido S, Kanzawa T, Kondo S, Kondo Y, (2005) Radiation-induced autophagy is associated with LC3 and its inhibition sensitizes malignant glioma cells. Int J Oncol 26: 1401-1410.
39. Ito H, Aoki H, Kuhnel F, Kondo Y, Kubicka S, Wirth T, et al, (2006) Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst 98: 625-636. (Pubitemid 43904846)
40. Jiang H, Gomez-Manzano C, Aoki H, Alonso MM, Kondo S, McCormick F, et al, (2007) Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death. J Natl Cancer Inst 99: 1410-1414. (Pubitemid 351767180)
41. Xu J, Kochanek KD, Murphy SL, Tejada-Vera B, (2010) Final Data for 2007. National Vital Statistic Reports.
42. Johnstone RW, Ruefli AA, Lowe SW, (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108: 153-164. (Pubitemid 34161136)
43. Kamada Y, Funakoshi T, Shintani T, Nagano K, Ohsumi M, Ohsumi Y, (2000) Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J Cell Biol 150: 1507-1513.
44. Kang KB, Zhu C, Yong SK, Gao Q, Wong MC, (2009) Enhanced sensitivity of celecoxib in human glioblastoma cells: Induction of DNA damage leading to p53-dependent G1 cell cycle arrest and autophagy. Mol Cancer 8: 66.
45. Kang MR, Kim MS, Oh JE, Kim YR, Song SY, Kim SS, et al, (2009) Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 217: 702-706.
46. Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S, (2004) Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death Differ 11: 448-457. (Pubitemid 38489422)
47. Kanzawa T, Zhang L, Xiao L, Germano IM, Kondo Y, Kondo S, (2005) Arsenic trioxide induces autophagic cell death in malignant glioma cells by upregulation of mitochondrial cell death protein BNIP3. Oncogene 14: 980-991. (Pubitemid 40313875)
48. Katayama M, Kawaguchi T, Berger MS, Pieper RO, (2007) DNA damaging agent-induced autophagy produces a cytoprotective adenosine triphosphate surge in malignant glioma cells. Cell Death Differ 14: 548-558.
49. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, Choi KS, (2007) Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 67: 6314-6324. (Pubitemid 47037514)
50. Kim MS, Jeong EG, Ahn CH, Kim SS, Lee SH, Yoo NJ, (2008) Frameshift mutation of UVRAG, an autophagy-related gene, in gastric carcinomas with microsatellite instability. Hum Pathol 39: 1059-1063.
51. Klionsky DJ, (2005) The molecular machinery of autophagy: unanswered questions. J Cell Sci 118 (Pt 1): 7-18. (Pubitemid 40277100)
52. Lee JW, Jeong EG, Soung YH, Nam SW, Lee JY, Yoo NJ, Lee SH, (2006) Decreased expression of tumour suppressor Bax-interacting factor-1 (Bif-1), a Bax activator, in gastric carcinomas. Pathology 38: 312-315. (Pubitemid 44266628)
53. Liang C, Feng P, Ku B, Dotan I, Canaani D, Oh BH, Jung JU, (2006) Autophagic and tumour suppressor activity of a novel Beclin1-binding protein UVRAG. Nat Cell Biol 8: 688-699.
54. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H, Levine B, (1999) Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 402: 672-676. (Pubitemid 129516338)
55. Lock R, Roy S, Kenific CM, Su JS, Salas E, Ronen SM, Debnath J, (2011) Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol Biol Cell 22: 165-178.
56. Lomonaco SL, Finniss S, Xiang C, Decarvalho A, Umansky F, Kalkanis SN, et al, (2009) The induction of autophagy by gamma-radiation contributes to the radioresistance of glioma stem cells. Int J Cancer 125: 717-722.
57. Maiuri MC, Le Toumelin G, Criollo A, Rain JC, Gautier F, Juin P, et al, (2007) Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J 26: 2527-2539. (Pubitemid 46788315)
58. Marino G, Salvador-Montoliu N, Fueyo A, Knecht E, Mizushima N, Lopez-Otin C, (2007) Tissue-specific autophagy alterations and increased tumorigenesis in mice deficient in Atg4C/autophagin-3. J Biol Chem 282: 18573-18583. (Pubitemid 47100226)
59. Martinez-Outschoorn UE, Whitaker-Menezes D, Pavlides S, Chiavarina B, Bonuccelli G, Casey T, et al, (2010) The autophagic tumor stroma model of cancer or "battery-operated tumor growth": a simple solution to the autophagy paradox. Cell Cycle 09: 4297-4306.
60. Mathew R, Kongara S, Beaudoin B, Karp CM, Bray K, Degenhardt K, et al, (2007) Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 21: 1367-1381. (Pubitemid 46871040)
61. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, et al, (2009) Autophagy suppresses tumorigenesis through elimination of p62. Cell 137: 1062-1075.
62. Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N, et al, (2009) Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 11: 385-396.
63. Mellinghoff IK, Cloughesy TF, Mischel PS, (2007) PTEN-mediated resistance to epidermal growth factor receptor kinase inhibitors. Clin Cancer Res 13: 378-381. (Pubitemid 46225339)
64. Miracco C, Cosci E, Oliveri G, Luzi P, Pacenti L, Monciatti I, et al, (2007) Protein and mRNA expression of autophagy gene Beclin 1 in human brain tumours. Int J Oncol 30: 429-436.
65. Nedelsky NB, Todd PK, Taylor JP, (2008) Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim Biophys Acta 1782: 691-699.
66. Ohsumi Y, (2001) Molecular dissection of autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol 2: 211-216. (Pubitemid 33675746)
67. Ohsumi Y, Mizushima N, (2004) Two ubiquitin-like conjugation systems essential for autophagy. Semin Cell Dev Biol 15: 231-236. (Pubitemid 38251652)
68. Pillay V, Allaf L, Wilding AL, Donoghue JF, Court NW, Greenall SA, et al, (2009) The plasticity of oncogene addiction: implications for targeted therapies directed to receptor tyrosine kinases. Neoplasia 11: 448-458, 2 pp. following 58.
69. Pirtoli L, Cevenini G, Tini P, Vannini M, Oliveri G, Marsili S, et al, (2009) The prognostic role of Beclin 1 protein expression in high-grade gliomas. Autophagy 5: 930-936.
70. Prados MD, Lamborn KR, Chang S, Burton E, Butowski N, Malec M, et al, (2006) Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Neuro-oncol 8: 67-78. (Pubitemid 43154453)
71. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, et al, (2003) Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 112: 1809-1820. (Pubitemid 38063704)
72. Ray R, Chen G, Vande Velde C, Cizeau J, Park JH, Reed JC, et al, (2000) BNIP3 heterodimerizes with Bcl-2/Bcl-X(L) and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem 275: 1439-1448. (Pubitemid 30051204)
73. Reed JC, (2002) Apoptosis-based therapies. Nat Rev Drug Discov 1: 111-121. (Pubitemid 41646518)
74. Rich JN, Reardon DA, Peery T, Dowell JM, Quinn JA, Penne KL, et al, (2004) Phase II trial of gefitinib in recurrent glioblastoma. J Clin Oncol 22: 133-142. (Pubitemid 41095125)
75. Roy S, Debnath J, (2010) Autophagy and tumorigenesis. Semin Immunopathol 32: 383-396.
76. Salazar M, Carracedo A, Salanueva IJ, Hernandez-Tiedra S, Lorente M, Egia A, et al, (2009) Cannabinoid action induces autophagy-mediated cell death through stimulation of ER stress in human glioma cells. J Clin Invest 119: 1359-1372.
77. Schwarze PE, Seglen PO, (1985) Reduced autophagic activity, improved protein balance and enhanced in vitro survival of hepatocytes isolated from carcinogen-treated rats. Exp Cell Res 157: 15-28. (Pubitemid 16205864)
78. Shingu T, Fujiwara K, Bogler O, Akiyama Y, Moritake K, Shinojima N, et al, (2009) Inhibition of autophagy at a late stage enhances imatinib-induced cytotoxicity in human malignant glioma cells. Int J Cancer 124: 1060-1071.
79. Simonsen A, Tooze SA, (2009) Coordination of membrane events during autophagy by multiple class III PI3-kinase complexes. J Cell Biol 186: 773-782.
80. Stommel JM, Kimmelman AC, Ying H, Nabioullin R, Ponugoti AH, Wiedemeyer R, et al, (2007) Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies. Science 318: 287-290. (Pubitemid 47574858)
81. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al, (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996. (Pubitemid 40349501)
82. Szybka M, Zawlik I, Kulczycka D, Golanska E, Jesien E, Kupnicka D, et al, (2008) Elimination of wild-type P53 mRNA in glioblastomas showing heterozygous mutations of P53. Br J Cancer 98: 1431-1433. (Pubitemid 351543567)
83. Tallõczy Z, Jiang W, Virgin HW, Leib DA, Scheuner D, Kaufman RJ, et al, (2002) Regulation of starvation- and virus-induced autophagy by the eIF2alpha kinase signaling pathway. Proc Natl Acad Sci USA 99: 190-195. (Pubitemid 34060339)
84. Tasdemir E, Maiuri MC, Galluzzi L, Vitale I, Djavaheri-Mergny M, D'Amelio M, et al, (2008) Regulation of autophagy by cytoplasmic p53. Nat Cell Biol 10: 676-687. (Pubitemid 351772933)
85. Tiwari M, Bajpai VK, Sahasrabuddhe AA, Kumar A, Sinha RA, Behari S, Godbole MM, (2008) Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells. Carcinogenesis 29: 600-609. (Pubitemid 351404878)
86. Torres S, Lorente M, Rodriguez-Fornes F, Hernandez-Tiedra S, Salazar M, Garcia-Taboada E, et al, (2011) A combined preclinical therapy of cannabinoids and temozolomide against glioma. Mol Cancer Ther 10: 90-103.
87. Tsukada M, Ohsumi Y, (1993) Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett 333: 169-174. (Pubitemid 23306962)
88. Van Meir EG, Hadjipanayis CG, Norden AD, Shu HK, Wen PY, Olson JJ, (2010) Exciting new advances in neuro-oncology: the avenue to a cure for malignant glioma. CA Cancer J Clin 60: 166-193.
89. Vassey JW, Edmonds J, Irvin JL, Green JA, Irvin EM, (1955) Studies on the administration of quinacrine to tumor-bearing mice. Cancer Res 15: 573-578.
90. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al, (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110.
91. Voss V, Senft C, Lang V, Ronellenfitsch MW, Steinbach JP, Seifert V, Kogel D, (2010) The pan-Bcl-2 inhibitor (-)-gossypol triggers autophagic cell death in malignant glioma. Mol Cancer Res 8: 1002-1016.
92. Wang J, Whiteman MW, Lian H, Wang G, Singh A, Huang D, Denmark T, (2009) A non-canonical MEK/ERK signaling pathway regulates autophagy via regulating Beclin 1. J Biol Chem 284: 21412-21424.
93. Wang MY, Lu KV, Zhu S, Dia EQ, Vivanco I, Shackleford GM, et al, (2006) Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Cancer Res 66: 7864-7869. (Pubitemid 44299148)
94. Weihua Z, Tsan R, Huang WC, Wu Q, Chiu CH, Fidler IJ, Hung MC, (2008) Survival of cancer cells is maintained by EGFR independent of its kinase activity. Cancer Cell 13: 385-393. (Pubitemid 351609444)
95. Yang Z, Klionsky DJ, (2010) Eaten alive: a history of macroautophagy. Nat Cell Biol 12: 814-822.
96. Yokoyama T, Iwado E, Kondo Y, Aoki H, Hayashi Y, Georgescu MM, et al, (2008) Autophagy-inducing agents augment the antitumor effect of telerase-selve oncolytic adenovirus OBP-405 on glioblastoma cells. Gene Ther 15: 1233-1239.
97. Young AR, Narita M, Ferreira M, Kirschner K, Sadaie M, Darot JF, et al, (2009) Autophagy mediates the mitotic senescence transition. Genes Dev 23: 798-803.
98. Yue Z, Jin S, Yang C, Levine AJ, Heintz N, (2003) Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 100: 15077-15082. (Pubitemid 37518019)
99. Zhong Y, Wang QJ, Li X, Yan Y, Backer JM, Chait BT, et al, (2009) Distinct regulation of autophagic activity by Atg14L and Rubicon associated with Beclin 1-phosphatidylinositol-3-kinase complex. Nat Cell Biol 11: 468-476.
100. Zhuang W, Li B, Long L, Chen L, Huang Q, Liang Z, (2011) Induction of autophagy promotes differentiation of glioma-initiating cells and their radiosensitivity. Int J Cancer 129: 2720-2731.